ロード中...
Hepatitis B virus resistance to antiviral drugs: where are we going?
Chronic HBV infections remain a major public health problem worldwide. According to WHO estimates, more than 300 million people are chronically infected and exposed to the risk of developing severe complications including cirrhosis and hepatocellular carcinoma. Major progress in the treatment of chr...
保存先:
| 第一著者: | |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Blackwell Munksgaard
2011
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3096621/ https://ncbi.nlm.nih.gov/pubmed/21205147 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1478-3231.2010.02399.x |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|